2012-03-22
The first industrially produced vaccine against porcine cysticercosis is eagerly anticipated as a result of a new partnership between GALVmed, Indian Immunologicals Limited (IIL) and the University of Melbourne. The […]
2012-03-22
Interim CEO Steve Sloan’s last official function as GALVmed CEO was on 1 December 2011 when he attended the commissioning event for the equipment and facilities provided to the National […]
2012-03-22
Steve Sloan, GALVmed’s Chief Executive, completed fact-finding visits to Uganda, Kenya and Tanzania in October 2007 to discuss infect and treatment methodologies for East Coast fever (ECF). Mr Sloan was […]